Local and systemic glucocorticoid metabolism in inflammatory arthritis

Background: Isolated, primary synovial fibroblasts generate active glucocorticoids through expression of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). This enzyme produces cortisol from inactive cortisone (and prednisolone from prednisone). Objective: To determine how intact synovial tissue metabolises glucocorticoids and to identify the local and systemic consequences of this activity by examination of glucocorticoid metabolism in patients with rheumatoid arthritis (RA). Methods: Synovial tissue was taken from patients with RA during joint replacement surgery. Glucocorticoid metabolism in explants was assessed by thin-layer chromatography and specific enzyme inhibitors. RT-PCR and immunohistochemistry were used to determine expression and distribution of 11β-HSD enzymes. Systemic glucocorticoid metabolism was examined in patients with RA using gas chromatography/mass spectrometry. Results: Synovial tissue synthesised cortisol from cortisone, confirming functional 11β-HSD1 expression. In patients with RA, enzyme activity correlated with donor erythrocyte sedimentation rate (ESR). Synovial tissues could also convert cortisol back to cortisone. Inhibitor studies and immunohistochemistry suggested this was owing to 11β-HSD2 expression in synovial macrophages, whereas 11β-HSD1 expression occurred primarily in fibroblasts. Synovial fluids exhibited lower cortisone levels than matched serum samples, indicating net local steroid activation. Urinary analyses indicated high 11β-HSD1 activity in untreated patients with RA compared with controls and a significant correlation between total body 11β-HSD1 activity and ESR. Conclusions: Synovial tissue metabolises glucocorticoids, the predominant effect being glucocorticoid activation, and this increases with inflammation. Endogenous glucocorticoid production in the joint is likely to have an impact on local inflammation and bone integrity.

• Publication year

  2007

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2007-11-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/ard.2008.090662PMID 18420938PMCID 2564803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in male contraception.

  2008cited by this paper
• Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins.

  2006cited by this paper
• Differential expression, function and response to inflammatory stimuli of 11β-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation

  2006cited by this paper
• Population-based assessment of adverse events associated with long-term glucocorticoid use.

  2006cited by this paper
• Local Amplification of Glucocorticoids by 11β-Hydroxysteroid Dehydrogenase Type 1 Promotes Macrophage Phagocytosis of Apoptotic Leukocytes1

  2006cited by this paper
• Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?

  2005cited by this paper
• The expression of 11 beta-hydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities.

  2005cited by this paper
• Use of Oral Corticosteroids and Risk of Fractures

  2005cited by this paper
• A defect in cortisol production in rheumatoid arthritis: why are we still looking?

  2005cited by this paper
• Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study

  2005cited by this paper
• The Expression of 11β-Hydroxysteroid Dehydrogenase Type I by Lymphocytes Provides a Novel Means for Intracrine Regulation of Glucocorticoid Activities1

  2005cited by this paper
• A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells

  2004cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

  2004cited by this paper
• Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test.

  2003cited by this paper
• Corticosteroid insufficiency in acutely ill patients.

  2003cited by this paper
• Corticosteroid insufficiency in acutely ill patients.

  2003cited by this paper
• Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation

  2003cited by this paper
• Osteoblastic 11β‐Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure

  2002cited by this paper
• Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.

  2002cited by this paper
• Use of Inhaled Corticosteroids and Risk of Fractures

  2001cited by this paper
• Modulation of 11β‐Hydroxysteroid Dehydrogenase Isozymes by Proinflammatory Cytokines in Osteoblasts: An Autocrine Switch from Glucocorticoid Inactivation to Activation

  2001cited by this paper
• Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation.

  2001cited by this paper
• Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone.

  2000cited by this paper
• Use of Oral Corticosteroids and Risk of Fractures

  2000cited by this paper
• Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity.

  1999cited by this paper
• Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues.

  1998cited by this paper
• Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis.

  1998cited by this paper
• Immunohistochemical Localization of Type 1 11β-Hydroxysteroid Dehydrogenase in Human Tissues1

  1998cited by this paper
• Urinary free cortisone and the assessment of 11β‐hydroxysteroid dehydrogenase activity in man

  1996cited by this paper
• Risk factors for septic arthritis in patients with joint disease. A prospective study.

  1995cited by this paper
• Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme.

  1994cited by this paper
• Cloning and tissue distribution of the human 11 beta-hydroxysteroid dehydrogenase type 2 enzyme.

  1994cited by this paper
• Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis.

  1992cited by this paper
• Evidence for anti-inflammatory effect of normal circulating plasma cortisol.

  1986cited by this paper
• Catabolism and interconversion of cortisol and cortisone in human synovial tissue in vitro.

  1969cited by this paper
• Corticosteroid Metabolism and Rheumatoid Arthritis

  1966cited by this paper
• Corticosteroid Metabolism and Rheumatoid Arthritis

  1957cited by this paper
• Metabolites of hydrocortisone and cortisone in synovial fluid in rheumatoid arthritis.

  1956cited by this paper
• Hydrocortisone and cortisone injected into arthritic joints; comparative effects of and use of hydrocortisone as a local antiarthritic agent.

  1951cited by this paper
• Effect of cortisone and pituitary adrenocorticotropic hormone (ACTH) on rheumatic diseases.

  1950cited by this paper
• Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Expression of Type 2 11�-Hydroxysteroid Dehydrogenase and Corticosteroid Hormone Receptors in Early Human Fetal Life*

  year unknowncited by this paper

• Mediating role of maternal cortisol in the association between maternal serum creatinine and fetal cortisol exposure.

  2026cites this paper
• Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis.

  2024cites this paper
• Synovial expression of glucocorticoid receptor parallels fibroblast activation in patients with rheumatoid arthritis

  2024cites this paper
• Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines.

  2024cites this paper
• An updated review on systemic glucocorticoids in the prevention and treatment of bronchopulmonary dysplasia

  2023cites this paper
• 11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

  2023cites this paper
• Cerebrospinal fluid proteins in idiopathic intracranial hypertension: An exploratory SWATH proteomics analysis

  2023cites this paper
• Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis

  2023cites this paper
• Recycling glucocorticoids: therapeutic implications of the 11β-HSD1 enzyme system.

  2023cites this paper
• The role of pre-receptor glucocorticoid metabolism in chronic inflammatory disease-associated muscle atrophy

  2023cites this paper
• FX5, a non-steroidal glucocorticoid receptor antagonist, ameliorates diabetic cognitive impairment in mice

  2022cites this paper
• Inhibitory Effect of Periodontitis through C/EBP and 11β-Hydroxysteroid Dehydrogenase Type 1 Regulation of Betulin Isolated from the Bark of Betula platyphylla

  2022cites this paper
• Effects of HSD11B1 knockout and overexpression on local cortisol production and differentiation of mesenchymal stem cells

  2022cites this paper
• 11β-Hydroxysteroid Dehydrogenase Type 1 within Osteoclasts Mediates the Bone Protective Properties of Therapeutic Corticosteroids in Chronic Inflammation

  2022cites this paper
• Increased systemic and adipose 11β-HSD1 activity in idiopathic intracranial hypertension

  2022cites this paper
• Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis

  2021cites this paper
• University of Birmingham Global deletion of 11β-HSD1 prevents muscle wasting associated with glucocorticoid therapy in polyarthritis

  2021cites this paper
• Pleiotropic Effects of Glucocorticoids on the Immune System in Circadian Rhythm and Stress

  2021cites this paper
• Applications of Corticosteroid Therapy in Inflammatory Rheumatic Diseases

  2021cites this paper
• Endogenous Glucocorticoid Metabolism in Bone: Friend or Foe

  2021cites this paper
• Progesterone Receptor Signaling Selectively Modulates Cytokine-Induced Global Gene Expression in Human Cervical Stromal Cells

  2020cites this paper
• Glucocorticoids: surprising new findings on their mechanisms of actions

  2020cites this paper
• Inflammation and Skeletal Muscle Wasting During Cachexia

  2020cites this paper
• University of Birmingham Inflammation and skeletal muscle wasting during cachexia

  2020cites this paper
• Arthritis and the role of endogenous glucocorticoids

  2020cites this paper
• Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids

  2020cites this paper
• Investigating glucocorticoids as mediators of increased bone marrow adiposity and bone loss

  2020cites this paper
• Glucocorticoid Metabolism and Activation

  2019cites this paper
• Glucocorticoid signaling and osteoarthritis.

  2019cites this paper
• Glucocorticoids

  2019cites this paper
• Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis

  2019cites this paper
• A multi-modal MRI study of the central response to inflammation in rheumatoid arthritis

  2018cites this paper
• Systemic Effects of Epidural Corticosteroid Injection.

  2018cites this paper
• 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis

  2018cites this paper
• Glucocorticoid activation by 11-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study

  2018cites this paper
• The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps

  2018cites this paper
• Role of 11β-HSD type 1 in abnormal HPA axis activity during immune-mediated arthritis

  2018cites this paper
• Glucocorticoid activation by 11β‐hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross‐sectional study

  2018cites this paper
• Corticosterone suppresses IL-1β-induced mPGE2 expression through regulation of the 11β-HSD1 bioactivity of synovial fibroblasts in vitro

  2017cites this paper
• Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis

  2017cites this paper
• The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease

  2017cites this paper
• Explorer The anti-inflammatory and immunosuppressive effects of glucocorticoids , recent developments and mechanistic insights

  2017influential citation
• The Hepato-Hypothalamic-Pituitary-Adrenal-Renal Axis: Mathematical Modeling of Cortisol’s Production, Metabolism, and Seasonal Variation

  2017cites this paper
• CD14++ CD16− monocytes are the main source of 11&bgr;‐HSD type 1 after IL‐4 stimulation

  2017cites this paper
• 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI

  2017cites this paper
• Explorer 11-HSD 1 suppresses cardiac fibroblast CXCL 2 , CXCL 5 and neutrophil recruitment to the heart post

  2017cites this paper
• Chapter 60 – Glucocorticoid Therapy

  2017cites this paper
• Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Experimental Periodontitis Induced by Lipopolysaccharide from Porphyromonas gingivalis

  2017cites this paper
• Cortisol Metabolism as a Regulator of the Tissue-Specific Glucocorticoid Action

  2017cites this paper
• 3, 3′, 5‐triiodo‐L‐thyronine Increases In Vitro Chondrogenesis of Mesenchymal Stem Cells From Human Umbilical Cord Stroma Through SRC2

  2016cites this paper
• Decreased OxLDL uptake and cholesterol efflux in THP1 cells elicited by cortisol and by cortisone through 11β-hydroxysteroid dehydrogenase type 1.

  2016cites this paper
• Local corticosterone activation by 11β-hydroxysteroid dehydrogenase 1 in keratinocytes: the role in narrow-band UVB-induced dermatitis

  2016cites this paper
• 11β-Hydroxysteroid dehydrogenase type 1 and bone

  2016cites this paper
• The expression of 11β-hydroxysteroid dehydrogenase type 1 is increased in experimental periodontitis in rats

  2016cites this paper
• 11β‐Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation

  2016cites this paper
• The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity

  2016cites this paper
• Differential glucocorticoid metabolism in patients with persistent versus resolving inflammatory arthritis

  2015cites this paper
• Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment

  2015cites this paper
• The Dehydrogenase Hypothesis.

  2015cites this paper
• Differential expression of 11b-hydroxysteroid dehydrogenase type 1 and 2 in mild and moderate/severe persistent allergic nasal mucosa and regulation of their expression by Th2 cytokines

  2014cites this paper
• 11β-Hydroxysteroid Dehydrogenase Enzymes Modulate Effects of Glucocorticoids in Rheumatoid Arthritis Synovial Cells

  2014cites this paper
• TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle

  2014cites this paper
• Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling

  2014cites this paper
• 11β-Hydroxysteroid Dehydrogenase 1 Specific Inhibitor Increased Dermal Collagen Content and Promotes Fibroblast Proliferation

  2014cites this paper
• Glucocorticoid metabolism in rheumatoid arthritis

  2014cites this paper
• TNFα regulates cortisol metabolism in vivo in patients with inflammatory arthritis

  2014cites this paper
• Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa.

  2014cites this paper
• Use of prednisone with abiraterone acetate in metastatic castration-resistant prostate cancer.

  2014cites this paper
• TNF a-mediated Hsd 11 b 1 binding of NFk B p 65 is associated with suppression of 11 b-HSD 1 in muscle

  2014cites this paper
• lnvolvement of 1 1 fi-HSDIin metabolic syndrome and periodontal disease

  2014cites this paper
• Dominance of the strongest: inflammatory cytokines versus glucocorticoids.

  2014cites this paper
• Pro-Inflammatory Cytokine Induction of 11 β-hydroxysteroid Dehydrogenase Type 1 in A 549 Cells Requires Phosphorylation of C / EBPβ at Thr 235

  2013cites this paper
• Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease.

  2013cites this paper
• Involvement of 11β-HSD1 in metabolic syndrome and periodontal disease

  2013cites this paper
• 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.

  2013influential citation
• 60 – Glucocorticoid Therapy

  2013cites this paper
• Pro-Inflammatory Cytokine Induction of 11β-hydroxysteroid Dehydrogenase Type 1 in A549 Cells Requires Phosphorylation of C/EBPβ at Thr235

  2013cites this paper
• Endogenous Glucocorticoids and Bone

  2013cites this paper
• Characterisation of fibroblast-like synoviocytes from a murine model of joint inflammation

  2013cites this paper
• Glucocorticoid sensitivity in health and disease

  2013cites this paper
• Clinical Chemistry and Other Laboratory Tests on Mouse Plasma or Serum

  2013cites this paper
• 11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects.

  2013cites this paper
• Synovial DKK1 expression is regulated by local glucocorticoid metabolism in inflammatory arthritis

  2012influential citation
• Glucocorticoids in bone and joint disease: the good, the bad and the uncertain.

  2012cites this paper
• In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis

  2012cites this paper
• Sixty Years after Hench — Corticosteroids and Chronic Inflammatory Disease

  2012cites this paper
• Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 and 2 in Rheumatoid Arthritis

  2012cites this paper
• Serial Changes in Plasma Total Cortisol, Plasma Free Cortisol, and Tissue Cortisol Activity in Patients With Septic Shock: An Observational Study

  2012cites this paper
• Glucocorticoids, Inflammation, and Bone

  2012cites this paper
• A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease

  2012cites this paper
• Endogenous glucocorticoids in inflammation: contributions of systemic and local responses.

  2012cites this paper
• Expression of 11β-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments.

  2012cites this paper
• Sixty years after Hench--corticosteroids and chronic inflammatory disease.

  2012cites this paper
• Serum regulates cortisol bioactivity by corticosteroid‐binding globulin‐dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches

  2011cites this paper
• Anti-inflammatory glucocorticoid drugs: reflections after 60 years

  2011cites this paper
• Exogenous and endogenous glucocorticoids in rheumatic diseases.

  2011cites this paper
• Pharmacodynamics of glucocorticoids.

  2011cites this paper
• Localization, age- and site-dependent expression, and regulation of 11β-hydroxysteroid dehydrogenase type 1 in skin.

  2011cites this paper
• Glucocorticoid-Induced Osteoporosis – A Disorder of Mesenchymal Stromal Cells?

  2011cites this paper
• Factors determining the progression of nonalcoholic fatty liver disease : the role of abnormal fatty acid and glucocorticoid metabolism

  2011cites this paper